Financials

  • Market Capitalization 23.77 M
  • Employee 40
  • Founded 2015
  • CEO N/A
  • Website www.nextcure.com
  • Headquarter Delaware, United States
  • FIGI BBG00BTH5153
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.63
Rapporto prezzo/fatturato
27.98 K

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4537
BRNS
Barinthus Biotherapeutics plc - American Depositary Shares
0.61 USD0.00%-1.61%-12.86%-40.20%24.92 M USD
4548
MRKR
Marker Therapeutics, Inc. - Common Stock
1.44 USD-1.37%-13.77%+6.67%-8.28%24.01 M USD
4551
NRSN
NeuroSense Therapeutics Ltd. - Ordinary Shares
0.73 USD0.00%+7.35%+5.80%-64.73%23.77 M USD
4553
VYNE
VYNE Therapeutics Inc. - Common Stock
0.71 USD+7.58%+9.23%+16.39%-46.21%23.68 M USD

Notizie